Home/Filings/4/0001179110-11-011168
4//SEC Filing

Buckland Martin 4

Accession 0001179110-11-011168

CIK 0000919722other

Filed

Jul 21, 8:00 PM ET

Accepted

Jul 22, 7:52 PM ET

Size

17.8 KB

Accession

0001179110-11-011168

Insider Transaction Report

Form 4
Period: 2011-07-20
Buckland Martin
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (Right to buy)

    2011-07-20+32,08532,085 total
    Exercise: $0.79Exp: 2019-06-22Common Stock (32,085 underlying)
  • Award

    Employee Stock Option (Right to buy)

    2011-07-20+98,22098,220 total
    Exercise: $0.92Exp: 2020-05-28Common Stock (98,220 underlying)
  • Award

    Employee Stock Option (Right to buy)

    2011-07-20+26,19226,192 total
    Exercise: $0.84From: 2011-07-20Exp: 2015-12-01Common Stock (26,192 underlying)
  • Award

    Employee Stock Option (Right to buy)

    2011-07-20+19,64419,644 total
    Exercise: $0.87From: 2011-07-20Exp: 2016-12-01Common Stock (19,644 underlying)
  • Award

    Employee Stock Option (Right to buy)

    2011-07-20+52,38452,384 total
    Exercise: $0.70From: 2011-07-20Exp: 2014-09-30Common Stock (52,384 underlying)
Footnotes (9)
  • [F1]Received in connection with the business combination (the "Business Combination") between the Issuer and Astex Therapeutics Limited ("Astex"), in exchange for a stock option granted September 30, 2004 to acquire 40,000 shares of Astex common stock for 0.57 British Pounds Sterling.
  • [F2]Received in connection with the Business Combination between the Issuer and Astex, in exchange for a stock option granted December 1, 2005 to acquire 20,000 shares of Astex common stock for 0.68 British Pounds Sterling.
  • [F3]Received in connection with the Business Combination between the Issuer and Astex, in exchange for a stock option granted December 1, 2006 to acquire 15,000 shares of Astex common stock for 0.71 British Pounds Sterling.
  • [F4]Received in connection with the Business Combination between the Issuer and Astex, in exchange for a stock option granted June 24, 2008 to acquire 20,000 shares of Astex common stock for 0.59 British Pounds Sterling.
  • [F5]The option is vested as to 19,644 shares as of the July 20, 2011 date of grant. The original, pre-Business Combination vesting schedule continues, which original vesting schedule provided for vesting as to 1/4 of the shares on June 24, 2009 and as to 1/48th of the shares on each one month anniversary thereafter.
  • [F6]Received in connection with the Business Combination between the Issuer and Astex, in exchange for a stock option granted June 22, 2009 to acquire 24,500 shares of Astex common stock for 0.64 British Pounds Sterling.
  • [F7]The option is vested as to 16,043 shares as of the July 20, 2011 date of grant. The original, pre-Business Combination vesting schedule continues, which original vesting schedule provided for vesting as to 1/4 of the shares on June 22, 2010 and as to 1/48th of the shares on each one month anniversary thereafter.
  • [F8]Received in connection with the Business Combination between the Issuer and Astex, in exchange for a stock option granted May 28, 2010 to acquire 75,000 shares of Astex common stock for 0.75 British Pounds Sterling.
  • [F9]The option is vested as to 26,601 shares as of the July 20, 2011 date of grant. The original, pre-Business Combination vesting schedule continues, which original vesting schedule provided for vesting as to 1/4 of the shares on May 28, 2011 and as to 1/48th of the shares on each one month anniversary thereafter.

Issuer

SUPERGEN INC

CIK 0000919722

Entity typeother

Related Parties

1
  • filerCIK 0001525784

Filing Metadata

Form type
4
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 7:52 PM ET
Size
17.8 KB